Jinsheng Chen

USPTO Granted Patents = 33 (Patent Applications = 2)

CIPO Patents = 8

EPO Patents = 9 (Patent Applications = 4)

Average Co-Inventor Count = 7.6

ph-index = 9

Forward Citations = 188(Granted Patents)

Company Filing History:

30 out of 2,078

Janssen Pharmaceutica Nv

patents

2 out of 76

3-dimensional Pharmaceuticals, Inc.

patents

1 out of 3,684

Bristol-myers Squibb Compnay

patents

Years Active: 2006-2017

Loading Chart...

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9718820 - Substituted aza-bicyclic imidazole derivatives useful TRPM8 receptor modulators (2017-08-01),

2. 9526731 - Method of inhibiting C-KIT kinase (2016-12-27),

3. 9452996 - Inhibitors of c-fms kinase (2016-09-27),

4. 9409915 - Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators (2016-08-09),

5. 9403804 - Inhibitors of c-fms kinase (2016-08-02),

6. 9394289 - Inhibitors of c-fms kinase (2016-07-19),

7. 9296726 - Inhibitors of c-fms kinase (2016-03-29),

8. 9266866 - Inhibitors of C-FMS kinase (2016-02-23),

9. 9249163 - PDE10a inhibitors for the treatment of type II diabetes (2016-02-02),

10. 9221797 - Inhibitors of c-fms kinase (2015-12-29),

11. 9193736 - PDE 10a inhibitors for the treatment of type II diabetes (2015-11-24),

12. 9023846 - Substituted AZA-bicyclic imidazole derivatives useful as TRPM8 receptor modulators (2015-05-05),

13. 8933091 - Method of inhibiting C-KIT kinase (2015-01-13),

14. 8895584 - Inhibitors of c-fms kinase (2014-11-25),

15. 8859602 - Inhibitors of c-fms kinase (2014-10-14),

Title: Innovations and Contributions of Jinsheng Chen in Pharmaceutical Patents

Introduction: Jinsheng Chen, based in Exton, PA, is an accomplished inventor with a remarkable portfolio of 33 patents. His work primarily focuses on pharmaceutical innovations, particularly in the areas of pain management and cancer treatment. Chen's inventions underscore his commitment to advancing medical science and improving patient outcomes.

Latest Patents: Among Jinsheng Chen's latest innovations are significant patents that demonstrate his expertise in pharmacology. One of his notable inventions is related to "Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators." This invention addresses various disorders associated with the TRP M8 receptor, including inflammatory pain, neuropathic pain, and cardiovascular diseases aggravated by cold. His other recent patent, "Method of inhibiting C-KIT kinase," presents a method aimed at reducing kinase activity of C-KIT in a subject. This invention is critical for preventing and treating cell proliferative disorders, including various cancers.

Career Highlights: Jinsheng Chen has an impressive career, having worked with prominent companies such as Janssen Pharmaceutica and 3-Dimensional Pharmaceuticals, Inc. His contributions to these organizations have solidified his reputation as a leading inventor in the pharmaceutical field.

Collaborations: Throughout his career, Chen has collaborated with several notable colleagues, including Sanath K. Meegalla and Carl R. Illig. These partnerships have further enriched his research and development efforts, leading to groundbreaking innovations that have the potential to change healthcare practices.

Conclusion: Jinsheng Chen's contributions to pharmaceutical patents are significant and far-reaching. His inventions, particularly in the areas of pain management and cancer treatment, highlight his ingenuity and dedication to advancing medical science. With a strong track record of successful patents and collaborations, Chen continues to be a pivotal figure in the innovation landscape within the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.